Schedule 13G ownership disclosure
Audentes Therapeutics, Inc.
Security class unavailable · CUSIP: 05070R104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,678,864
- Percent of class
- 8.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-20-004619
- Form type
- SC 13G
- Filer
- Audentes Therapeutics, Inc.
- CIK
- CIK 1628738
- Filed
- Feb 05, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership